Fight's On For $50bn FDA/NIH 'Innovation' Fund
This article was originally published in Scrip
Unwilling to wait to fight it out on the Senate floor to figure out how much to put into a Republican-proposed pot of money to help support high-priority biomedical research and development projects, like President Barack Obama's Precision Medicine, BRAIN and Cancer Moon Shot initiatives, Democrats in the chamber's Health, Education, Labor and Pensions (HELP) Committee on March 3 introduced their own plan – proposing that $50bn over the next 10 years be added to the budgets of the FDA and the National Institutes of Health (NIH).
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.